1-229594383-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014409.4(TAF5L):āc.1684C>Gā(p.Gln562Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000157 in 1,614,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014409.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF5L | NM_014409.4 | c.1684C>G | p.Gln562Glu | missense_variant | 5/5 | ENST00000258281.7 | NP_055224.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF5L | ENST00000258281.7 | c.1684C>G | p.Gln562Glu | missense_variant | 5/5 | 5 | NM_014409.4 | ENSP00000258281.2 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251408Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135884
GnomAD4 exome AF: 0.000152 AC: 222AN: 1461854Hom.: 0 Cov.: 30 AF XY: 0.000151 AC XY: 110AN XY: 727226
GnomAD4 genome AF: 0.000204 AC: 31AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.1684C>G (p.Q562E) alteration is located in exon 5 (coding exon 4) of the TAF5L gene. This alteration results from a C to G substitution at nucleotide position 1684, causing the glutamine (Q) at amino acid position 562 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at